CardioExchange Archive

April 4th, 2011

Viewing the ACC from Afar: It Is Not the Same

John Ryan, MD

Several Cardiology Fellows who are attending ACC.11 this week are blogging together on CardioExchange. The Fellows include Sandeep Mangalmurti, Hansie Mathelier, John Ryan (moderating and providing an outsider’s view from Chicago), Amit Shah, and Justin Vader. See the previous post in this series, and check back often to learn about the biggest buzz in New […]

---

April 4th, 2011

ACC.11: CardioExchange Coverage Roundup

CardioExchange Editors, Staff

Whether you’re attending ACC.11 or not, check out our coverage of late-breaking clinical trials, interviews with the authors of the most important research, and blogs from our fellows on the most interesting presentations at the meeting. VIEWS AND ANALYSIS PARTNER A: An Investigator’s View: Michael Mack, a principal investigator of the PARTNER study of TAVI […]

---

April 3rd, 2011

The Cardiology Profession: At the Table or on the Menu?

Sandeep Mangalmurti, MD, JD

Several Cardiology Fellows who are attending ACC.11 this week are blogging together on CardioExchange. The Fellows include Sandeep Mangalmurti, Hansie Mathelier, John Ryan (moderating and providing an outsider’s view from Chicago), Amit Shah, and Justin Vader. See the previous post in this series, and check back often to learn about the biggest buzz in New […]

---

April 3rd, 2011

From Far in the Future to the Here and Now: Reflections on the Translational Research Symposium and a Session on VADs

Justin M Vader, M.D.

Several Cardiology Fellows who are attending ACC.11 this week are blogging together on CardioExchange. The Fellows include Sandeep Mangalmurti, Hansie Mathelier, John Ryan (moderating and providing an outsider’s view from Chicago), Amit Shah, and Justin Vader. See the next post in this series, and check back often to learn about the biggest buzz in New […]

---

April 3rd, 2011

TAVI: PARTNER or Blind Date?

Richard A. Lange, MD, MBA

Almost 700 patients with severe aortic stenosis who were considered “high risk” for conventional valve replacement (AVR) were randomized to transcatheter aortic valve implantation (TAVI) or AVR. In comparison to AVR, TAVI was associated with a higher incidence of stroke (5.1% vs 2.4% at one year), vascular complications (11.0% vs 3.2% at 30 days), and […]

---

April 1st, 2011

Who’s Paying for the Fellows?

John Ryan, MD

Several Cardiology Fellows who are attending ACC.11 this week are blogging together on CardioExchange. The Fellows include Sandeep Mangalmurti, Hansie Mathelier, John Ryan (moderating and providing an outsider’s view from Chicago), Amit Shah, and Justin Vader. See the next post in this series, and check back often to learn about the biggest buzz in New […]

---

March 31st, 2011

A Delectable Side Benefit of ACC — New Orleans Restaurants

John Ryan, MD

Obviously, the emphasis at ACC is on science and research. However, we all know that these meetings provide unique opportunities for reunions and social events for traveling cardiologists. For me, one of the highlights of any meeting is when my faculty arranges a dinner or when I can get away with others from the stressors […]

---

March 30th, 2011

Choosing a PARTNER for Life: A or B?

Richard A. Lange, MD, MBA and L. David Hillis, MD

What is TAVI? During Transcatheter Aortic Valve Implantation (TAVI), a bioprosthetic valve is inserted through a catheter and implanted within the native stenotic aortic valve. The self-expanding CoreValve (Medtronic) and balloon-mounted Edwards SAPIEN (Edwards Lifesciences) valve are approved in Europe and under investigation in the U.S. for TAVI and can be implanted via the transfemoral, subclavian, or […]

---

March 29th, 2011

Conflicts of Interest in Cardiovascular Guidelines

Larry Husten, PHD

More than half of authors and reviewers of cardiovascular clinical practice guidelines (CPGs) have at least one conflict of interest (COI), according to a study in the Archives of Internal Medicine. Todd Mendelson and colleagues analyzed the 17 most recent ACC/AHA CPGs through 2008 and found that 56% of the participants reported a COI. The […]

---

March 28th, 2011

Updated Unstable Angina/Non-STEMI Guidelines Released by ACC & AHA

Larry Husten, PHD

The AHA and ACC have released a focused update of the 2007 guidelines for the management of unstable angina and non-STEMI. The guidelines incorporate new information from recent clinical trials, and deal with controversial topics such as the choice of antiplatelet agents, the use of platelet-function and genetic tests with antiplatelet agents, and the timing […]

---